Cruiser Capital Advisors’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$114K Hold
48,900
– – 0.04% 40
2026
Q2
$63.6K Hold
48,900
– – 0.04% 41
2026
Q1
$70.9K Hold
48,900
– – 0.03% 42
2025
Q4
$67.5K Sell
48,900
-1,100
-2% -$2.3K 0.06% 44
2025
Q3
$136K Hold
50,000
– – 0.14% 44
2025
Q2
$174K Hold
50,000
– – 0.08% 37
2025
Q1
$184K Buy
+50,000
New +$183K 0.25% 38

Other funds holding STIM

Cruiser Capital Advisors's STIM Position: Q3 2026 in Review

Cruiser Capital Advisors held its Neuronetics (STIM) position steady in Q3 2026 at 48,900 shares worth $114K. The position accounts for 0.04% of the portfolio, ranked #40.

Cruiser Capital Advisors first reported a position in STIM in Q1 2025 and has held it in 7 quarters since. The position peaked at $184K in Q1 2025. 95 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Cruiser Capital Advisors held 48,900 shares of Neuronetics worth $114K as of Q3 2026.
  • Cruiser Capital Advisors left its Neuronetics share count unchanged in Q3 2026.
  • Neuronetics made up 0.04% of Cruiser Capital Advisors's portfolio in Q3 2026, its #40 holding.
  • Cruiser Capital Advisors first reported a position in Neuronetics in Q1 2025 and has held it in 7 quarters since.
  • Cruiser Capital Advisors's Neuronetics position peaked at $184K in Q1 2025.
  • 95 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Cruiser Capital Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.